(The FDA has received more than 700 adverse event reports tied to compounded GLP-1s, but its not clear if the events were caused by the drugs.) The companies also see compounders as a threat to their obesity drug sales, which are estimated to balloon to $100 billion a year by 2030
Kisspeptin Top 5 Uses: Infertility treatment Ovulation induction PCOS support Hypothalamic amenorrhea Hormonal diagnostics Reported Side Effects: Mild flushing, abdominal cramping, headache, rare nausea
Elimination Mean elimination half-life (T1/2) of tesamorelin was 26 and 38 minutes in healthy subjects and HIV-infected patients, respectively, after subcutaneous administration for 14 consecutive days
It's fundamental to good care
What most articles get wrong about "equivalent doses" The most common error in published conversion guidance is presenting a fixed ratio table (e.g., "Wegovy 1.0 mg = Zepbound 5 mg") without explaining that these are population-level statistical approximations, not individual dose prescriptions